Traws Pharma, Inc. Share Price
Traws Pharma, Inc. (TRAW) had Share Price of $22.65 per share as of 2021-02-17, per its 10-Q filed 2022-08-15.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:SharePrice · last filed 2022-08-15
- 2021-02-17: Share Price $22.65.
- 2020-07-09: Share Price $8.40; Share Price as first filed $1.44.
- 2019-11-21: Share Price $0.20.
- 2016-01-05: Share Price $2137.50; Share Price as first filed $142.50.
| Period end | Share Price | Share Price as first filed |
|---|---|---|
| 2021-02-17 | $22.65 10-Q · filed 2022-08-15 | |
| 2020-07-09 | $8.40 10-Q · filed 2022-08-15 | $1.44 10-Q · filed 2020-11-16 |
| 2019-11-21 | $0.20 10-K · filed 2021-03-18 | |
| 2016-01-05 | $2137.50 10-Q · filed 2021-11-15 | $142.50 10-Q · filed 2019-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |